Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
US8785448B2 · kind B2 · utility
0Cited by
6References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2013 |
| Grant date | Jul 22, 2014 |
| Priority date | — |
| Expiry date | Aug 27, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds represented by formula (Ia) or (Ib) and wherein R and R1 are as defined in the description, and pharmaceutically acceptable salts thereof, are disclosed; the said compounds are useful in the treatment of cell cycle proliferative disorders, e.g. cancer, associated with an altered cell cycle dependent kinase activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.